ligands acting on targets

(S)-EF-1520.

(S)-EF-1520.

(S)-Enzaplatovir ((S)-BTA-C585) is the S-enantiomer of Enzaplatovir. (S)-Enzaplatovir shows antiviral activities with an EC 50 of 56 nM for respiratory syncytial viral (RSV) (patent WO2011094823A1 compound 77).Form:Solid.

(S)-Enzaplatovir ((S)-BTA-C585) is the S-enantiomer of Enzaplatovir. (S)-Enzaplatovir shows antiviral activities with an EC 50 of 56 nM for respiratory syncytial viral (RSV) (patent WO2011094823A1 compound 77).Form:Solid.

(S)-Enzaplatovir ((S)-BTA-C585) is the S-enantiomer of Enzaplatovir. (S)-Enzaplatovir shows antiviral activities with an EC 50 of 56 nM for respiratory syncytial viral (RSV) (patent WO2011094823A1 compound 77).

(S)-ErSO is the dextrorotatory enantiomer of ErSO. (S)-ErSO is inactive in MCF-7 cells (from patent WO2020009958A1, compound (s)-105).In Vitro(-)-ErSO induces dose-dependent death of MCF-7 cells. (+)-l05 is inactive. MCE has not independently

(S)-ErSO is the dextrorotatory enantiomer of ErSO. (S)-ErSO is inactive in MCF-7 cells (from patent WO2020009958A1, compound (s)-105).In Vitro(-)-ErSO induces dose-dependent death of MCF-7 cells. (+)-l05 is inactive. MCE has not independently

(S)-ErSO is the dextrorotatory enantiomer of ErSO. (S)-ErSO is inactive in MCF-7 cells (from patent WO2020009958A1, compound (s)-105).In Vitro(-)-ErSO induces dose-dependent death of MCF-7 cells. (+)-l05 is inactive. MCE has not independently

(S)-ESBA HCl is a potent and selective mouse/rat kynurenine aminotransferase II (KAT II) inhibitor.(S)-ESBA hydrochlorideis a mouse and rat KAT II inhibitor.

(S)-ESBA HCl is a potent and selective mouse/rat kynurenine aminotransferase II (KAT II) inhibitor.(S)-ESBA hydrochlorideis a mouse and rat KAT II inhibitor.

(S)-flurocarazolol.

(S)-flurocarazolol.